Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of S-1 with concurrent radiotherapy followed by S-1 chemotherapy for locally advanced pancreatic cancer
ChiCTR-TNC-10000929Phase 2Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in pancreatic adenocarcinoma (PDAC), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Response rate. Started Jun 2010; status: completed.
02
Drugs
tegafur
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on ChiCTR-TNC-10000929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000929.